Medscape

TAVR Use Expands in Younger Patients, Outpacing Data on Device Durability, Repeat Procedures

Once reserved for very high-risk patients, the use of transcatheter aortic valve replacement in low-risk cases has increased ...
EurekAlert!

Younger patients with asymptomatic aortic stenosis who undergo transcatheter aortic valve replacement experience lower rates of serious cardiovascular events, including stroke

Washington, D.C. – May 2, 2025 – New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a strategy of early intervention with ...

How TAVR Is Changing Heart Care for High‑Risk Patients

TAVR is a less invasive procedure than traditional open-heart surgery, offering faster recovery, reduced risk, and shorter ...
The New England Journal of Medicine

Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years

A previous analysis in this trial showed that among patients with severe, symptomatic aortic stenosis who were at low surgical risk, the rate of the composite end point of death, stroke, or ...

Minimally invasive procedure helps patients with aortic stenosis live longer

Aortic stenosis is when the heart’s main valve becomes stiff and narrowed, making it harder for blood to flow to the rest of the body. When it becomes severe, it can lead to life-threatening ...
Healio

More younger patients opt for TAVR vs. surgery, despite poorer outcomes

Please provide your email address to receive an email when new articles are posted on . Transcatheter aortic valve replacement for younger adults with severe aortic stenosis rose nearly ninefold from ...
Medscape

TAVR vs Surgery in Intermediate-Risk Patients: Clues From OBSERVANT

WASHINGTON, DC — New European registry data on transcatheter aortic-valve replacement (TAVR) in patients at lower surgical risk than those studied in the pivotal randomized trials offers the ...
Kaleido Scope

Still and Cardiothoracic Surgery faculty publish findings on outcomes for high-risk patients following TAVR explantations

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...
News Medical

Heart failure patients benefit from dapagliflozin after TAVR procedure

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...
Nasdaq

Abbott Receives FDA Approval for Minimally Invasive Portico™ with FlexNav™ TAVR System to Treat Patients with Aortic Valve Disease

- Transcatheter aortic valve replacement (TAVR) procedure treats people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery - With Portico approval, Abbott ...
EurekAlert!

Dapagliflozin safe and effective in elderly patients with heart failure undergoing valve replacement

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...
TCTMD

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

SAN FRANCISCO, CA—Conduction abnormalities like complete heart block (CHB) and left bundle branch block (LBBB) remain common in today’s TAVI patients, with some facing pacemaker implantation or even ...